Share on

Global Cell Fractionation Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product, Type Of Cell, End User & Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 2538
Pages: 175
Formats: report pdf report excel report power bi report ppt

Global Cell Fractionation Market Size (2022 to 2027)

The size of the global cell fractionation market is estimated to be growing at a CAGR of 10.50% during the forecast period. The size of the market is predicted to be worth USD 5.83 billion by 2027 from USD 3.54 billion in 2022. Cell fractionation is also known as cell lysis as it owning a process to separate cellular components while preserving the individual functions of each component. 


The global cell fractionation market is mainly driven by factors such as the government's increment for research, expansion of biotechnology and biopharmaceutical industries, an increase of high prevalence of diseases, and a growing focus on personalized medicine.

Increased government support for research, expanding biotechnology and biopharmaceutical markets, a high prevalence of diseases, and a rising emphasis on personalized medicine drive this market development. Due to increased government spending in most countries and an aging population, North America has accounted for the highest share in the global market in 2020. Researchers use disruptive cells to investigate the morphology and structure of organelles and produce novel cell therapies and other cell-based treatments. Due to the significance of cell-based science, several government agencies have expanded their funding to expand such studies. As a result, many government agencies have offered financial assistance in investments and funds. Moreover, there is a massive increase in infectious diseases in the present situation, which is propelling the market's growth rate. 


Some of the restraints in the cell fractionation market are high expenditure or cost of cell-based research. Cell-based research providers or public servicers should spend high expenditure. Lack of skilled personnel is also limiting the growth rate of the market. The shortage of experienced professionals is a significant restraint in the Cell Fractionation market. Moreover, the survival of new entrants is also leading as a restraint in the Cell Fractionation market. 


Developing countries are expected to have high-growth opportunities for cell lysis/cell fractionation industry players. The major causes for this are the rising prevalence of chronic diseases, scientific technology developments, and supportive regulation in developing countries for cell-based research. Mammalian cells are the most widely fractionated cell types, owing to increased investments in cell-based science by businesses and governments and the rising prevalence of diseases such as HIV/AIDS and cancer. As a result, key industry players are expanding their presence in emerging markets such as China by developing new facilities as well as R&D and innovation centers in the country. Some of the major players, such as Thermo Fisher Scientific Inc. (US) and Merck KGaA (Germany), have implemented numerous growth strategies, such as mergers and acquisitions, new product releases, extensions, alliances, joint ventures, collaborations, and others, to improve their position in this market in the future.

Impact of Covid-19 on the global cell fractionation market:

The cell fractionation market is affected by COVID-19 in many ways, especially economically. COVID-19 impacted the cell fractionation market in financial growth. Moreover, the supply chain of manufactured products is affected by the COVID-19 pandemic. The cell fractionation market will regain the loss that occurred by the pandemic. The cell fractionation market will be on track in the upcoming years.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Product, Cell Type, End-User, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa


This research report has been segmented and sub-segmented the global cell fractionation market based on the product, cell type, end-user, and region.

Cell Fractionation Market - By Product:

  • Consumables
  • Reagents
    • Enzymes
    • Detergent Solutions
  • Beads
  • Disposables
  • Instruments
    • Sonicator
    • Homogenizer

By product, the consumables segment is accounting for the largest share across the globe. The enzymes are most frequently used for chemical cell disruption and forming a significant portion of the reagents and kits market. Sonicator is accounting for the largest share in the Cell fractionation market by owning factors like increment of cell lysis usage by instruments division. Moreover, the major restraint of the cell lysis market is the high cost of Sonicators.  

Cell Fractionation Market – By Cell Type:

  • Microbial
  • Mammalian

Based on cell type, the Mammalian segment leads the market because of the rising aging population. The mammalian cells segment is expected to account for the largest share of this market, owing to rising investments by governments and companies for cell-based research. The rising prevalence of diseases such as cancer, HIV/AIDS urges a demand for advanced treatment options and the development of cell therapies. It increases the market growth of mammalian and microbial cells.

Cell Fractionation Market – By End User:

  • Research Laboratories
  • Biopharmaceutical
  • Biotechnology Companies

Based on the end-user, the Research Laboratories segment accounts for the largest share by end-user segment in the cell fractionation market. There are many attributing factors in the research laboratories and institutes segment. Some of the contributing factors are the increment in the prevalence of diseases and the rise of government investments. 

Cell Fractionation Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

North America leads the global cell fractionation market with the highest share because of advancements in the biotechnology market and commercialization. Factors like the advantageous rise of the old citizen population and the surge of government funds are majorly propelling the market's growth rate in this region.

Asia Pacific is anticipated to hit the highest CAGR in the coming years. The Asia-Pacific region has attributing factors like the presence of strong key players in countries like China and India and the rise in the growth of the aging population. Europe is recording as the strongest contender in the cell fractionation market as the European region is also compressing advantageous factors such as the improvement of advanced technology. 


Some of the prominent companies leading the global cell fractionation market profiled in this report are Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., F. Hoffman-La Roche AG, Merck KGaA, Miltenyi Biotec, QIAGEN N., Qsonica and Thermo Fisher Scientific Inc.


Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample